Free cash flow was negative $73,000,000 in Q2, which reflects the impact of collecting seasonally lower Q1 revenue in Q2. Over the trailing 12 months, free cash flow was positive $15,000,000 dollars while operating cash flow was positive $244,000,000 as we continue to balance investments with top line growth to deliver sustained positive cash flow. Dilution or year over year growth in our share count was 1.9% in Q2, down from 3.8% in the prior quarter. As part of our efforts to responsibly manage the impact of SBC on our share count, we repurchased 7,000,000 shares at a cost of 76,000,000 in Q2, reflecting an average share repurchase price of $11.06 Since we began opportunistically managing our share count through share repurchases in Q3 of 2022, we have repurchased 151,500,000 shares, representing 8.4 percent of fully diluted shares outstanding at an average price of $9.91 per share and a total cost of $1,500,000,000 In Q2, we issued $750,000,000 in convertible notes returning in 2,030 with a coupon of 50 basis points. In addition, we negotiated the repurchase of $148,000,000 of our 2025 convertible notes and $238,000,000 of our 2026 convertible notes.